Calcium channel blockers and β-blockers in relation to Parkinson’s disease

We investigated the risk of PD associated with calcium channel blockers (CCBs) and β-blockers in a population-based case-control study of 206 men and women between ages 35 and 89 with a new diagnosis of idiopathic PD between 1992 and 2002, and 383 controls without PD or other neurodegenerative disor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ton, Thanh G.N., Heckbert, Susan R., Longstreth, W.T., Rossing, Mary Anne, Kukull, Walter A., Franklin, Gary M., Swanson, Phillip D., Smith-Weller, Terri, Checkoway, Harvey
Formato: Artigo
Idioma:Inglês
Publicado em: 2006
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1893113/
https://ncbi.nlm.nih.gov/pubmed/17055323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.parkreldis.2006.08.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados